<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03171740</url>
  </required_header>
  <id_info>
    <org_study_id>VictorSoutoAnestesiologia2017</org_study_id>
    <nct_id>NCT03171740</nct_id>
  </id_info>
  <brief_title>Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children</brief_title>
  <official_title>Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children: Superiority Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brasilia University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brasilia University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study where children will receive one premedication, either intranasal dexmedetomidine or
      oral midazolam, to reduce agitation on emergence of anesthesia. The hypothesis is that
      dexmedetomidine is superior but previous studies lack quality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children will be randomized to receive, either midazolam (0.5mg/kg) or dexmedetomidine
      (1mcg/kg), as anesthetic premedication. Emergence agitation will be assessed by PAED scale.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">January 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All participants will receive an intranasal and an oral drug. One group will receive oral midazolam and intranasal saline, the other will receive oral saline and intranasal dexmededomedine.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants will not know which group they will be allocated. The anesthesia care provider will not know which premedication the patient received because another professional, who is not from the research team, will provide it to the child. The investigator and outcome assessor will only know the allocated group latter by a code which will be revealed after the end of the analysis.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Emergence agitation</measure>
    <time_frame>15 minutes</time_frame>
    <description>Anesthesiologist provider's reported score on PAED (Paediatric Anesthesia Emergence Scale) during the first 15 minutes after the extubation. The PAED consists of four items. Each item is scored 0-4 yielding a total between 0 and 20.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bradycardia</measure>
    <time_frame>2 hours</time_frame>
    <description>It is defined as a heart rate lower than the expected for the age or a drop higher than 30% of the patient's lowest previous heart rate registered. It will be measured using pletysmography and ECG beat-by-beat during the surgery and it will be true if it occurs at least once.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypotension</measure>
    <time_frame>2 hours</time_frame>
    <description>It is defined as a mean arterial pressure lower than the expected for the age or a drop higher than 30% of the patient's lowest previous mean arterial pressure registered. It will be measured using oscillatory method every 5 minutes during the surgery and it will be true if it occurs at least once.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>15-minutes</time_frame>
    <description>It will be measured in the first 15 minutes after the induction of general anesthesia using an ocular tonometer. It is measured in mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory depression</measure>
    <time_frame>30 minutes</time_frame>
    <description>Anesthesiologist provider's reported incidence respiratory depression in the child, before induction of general anesthesia. It will be true if the respiratory rate is slow for the age and the variable is dichotomic (true or false).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paradoxal agitation</measure>
    <time_frame>30 minutes</time_frame>
    <description>Anesthesiologist provider's reported incidence paradoxal agitation in the child, before induction of general anesthesia. The assessment subjective and the variable is dichotomic (true or false).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Emergence Delirium</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children will receive 1mcg/kg intranasal dexmedetomidine and oral saline, 30 minutes before going to operation theater.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam oral solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children will receive 0,5mg/kg oral midazolam and intranasal saline, 30 minutes before going to operation theater.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Intranasal dexmedetomidine, 1mcg/kg (it is a 100mcg/ml solution)</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam oral solution</intervention_name>
    <description>Oral midazolam, 0.5mg/kg (its a 2mg/ml solution)</description>
    <arm_group_label>Midazolam oral solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral saline</intervention_name>
    <description>Oral saline, 0.25ml/kg</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>0.9% Saline solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal saline</intervention_name>
    <description>Nasal saline 0.01ml/kg</description>
    <arm_group_label>Midazolam oral solution</arm_group_label>
    <other_name>0.9% Saline solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for amygdalectomy

          -  American Society of Anesthesiologists Physical Status PI or PII

          -  Absence of congenital neuropathy

          -  Absence of cardiac pathology (any)

          -  Intolerance to one of the studied drugs.

        Exclusion Criteria:

          -  Protocol violation

          -  Need to transfer for ICU intubated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel MN Guimar√£es, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Brasilia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel MN Guimaraes, MD</last_name>
    <phone>+5561996455997</phone>
    <email>gabrielmng@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Brasilia University</name>
      <address>
        <city>Brasilia</city>
        <state>Distrito Federal</state>
        <zip>7000000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel MN Guimaraes, MD</last_name>
      <phone>+55 61 99645-5997</phone>
      <email>gabrielmng@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brasilia University Hospital</investigator_affiliation>
    <investigator_full_name>Gabriel Magalhaes Nunes Guimaraes</investigator_full_name>
    <investigator_title>Head of anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Emergence Delirium</keyword>
  <keyword>Emergence Agitation</keyword>
  <keyword>premedication</keyword>
  <keyword>dexmedetomidine</keyword>
  <keyword>midazolam</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Plan to share the database used for analysis, without any variable that may help to identify individuals (such as name, register), to facilitate meta-analysis and re-analysis.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

